Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

NCT04194684 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: nab-paclitaxel

Sponsor

Chinese Academy of Medical Sciences